USBC, Inc. (USBC)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist USBC, Inc. (USBC) ein Technology-Unternehmen mit einer Bewertung von 0. Bewertet mit 43/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026USBC, Inc. (USBC) Technologieprofil & Wettbewerbsposition
USBC, Inc. is a technology company focused on digital financial technologies and non-invasive health monitoring research. The company develops digital assets, banking solutions, and material analysis technologies, positioning itself in the evolving landscape of fintech and health tech within the scientific and technical instruments industry.
Investmentthese
USBC, Inc. presents a unique investment opportunity within the intersection of fintech and health tech. The company's focus on digital assets, banking solutions, and non-invasive health monitoring positions it to capitalize on the growing demand for innovative financial and healthcare technologies. With a market capitalization of $0.13 billion and a debt-to-equity ratio of 0.35, USBC demonstrates a moderate level of financial leverage. However, the company's negative return on equity (-46.6%) and negative free cash flow ($-0.00B) highlight the challenges it faces in achieving profitability and sustainable growth. Key catalysts include the successful development and commercialization of its non-invasive health monitoring technologies and the expansion of its digital financial services offerings. Potential risks include regulatory hurdles in the fintech sector and competition from established players in both the financial and healthcare industries.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.13 billion indicates the company's current valuation in the market.
- Debt-to-equity ratio of 0.35 suggests a moderate level of financial leverage.
- Negative return on equity of -46.6% reflects challenges in generating profits from shareholder equity.
- Negative free cash flow of $-0.00B indicates the company is currently not generating positive cash flow from its operations.
- Beta of 1.67 suggests the stock is more volatile than the market average.
Staerken
- Innovative technology in digital finance and health monitoring
- Expertise in electromagnetic energy-based material analysis
- Potential for high growth in emerging markets
- Strong focus on research and development
Schwaechen
- Negative return on equity
- Negative free cash flow
- Limited market presence compared to established competitors
- Dependence on successful commercialization of new technologies
Katalysatoren
- Upcoming: Launch of new digital financial services platform.
- Upcoming: Completion of clinical trials for non-invasive health monitoring device.
- Ongoing: Expansion of strategic partnerships with financial institutions.
- Ongoing: Development of AI-driven solutions for personalized financial advice.
Risiken
- Potential: Regulatory changes impacting the fintech industry.
- Potential: Competition from established players in the financial and healthcare sectors.
- Ongoing: Challenges in achieving profitability and sustainable growth.
- Ongoing: Dependence on successful commercialization of new technologies.
Wachstumschancen
- Expansion of Digital Financial Services: USBC, Inc. can expand its digital financial services by developing new products and services, such as cryptocurrency wallets, decentralized lending platforms, and blockchain-based payment systems. The global fintech market is projected to reach $305 billion by 2025, offering significant growth potential. Timeline: Ongoing.
- Commercialization of Non-Invasive Health Monitoring Technologies: The company's research in non-invasive health monitoring could lead to the development of wearable devices and remote monitoring systems for chronic diseases. The global remote patient monitoring market is expected to reach $175 billion by 2027, presenting a substantial market opportunity. Timeline: Upcoming.
- Strategic Partnerships: USBC, Inc. can form strategic partnerships with established financial institutions and healthcare providers to expand its market reach and access new customer segments. Collaborations with major players in these industries can accelerate the adoption of its technologies and enhance its credibility. Timeline: Ongoing.
- Geographic Expansion: The company can expand its operations beyond the United States to target international markets with high growth potential in fintech and health tech. Emerging economies in Asia and Latin America offer significant opportunities for digital financial services and remote healthcare solutions. Timeline: Upcoming.
- Development of AI-Driven Solutions: USBC, Inc. can leverage artificial intelligence and machine learning to enhance its products and services, such as personalized financial advice, predictive health analytics, and automated fraud detection. The AI in healthcare market is projected to reach $34 billion by 2027, indicating a growing demand for AI-powered solutions. Timeline: Ongoing.
Chancen
- Expansion into new geographic markets
- Strategic partnerships with major financial institutions
- Increased adoption of digital financial services
- Growing demand for non-invasive health monitoring solutions
Risiken
- Regulatory hurdles in the fintech sector
- Competition from established players in the financial and healthcare industries
- Rapid technological changes
- Economic downturns affecting consumer spending
Wettbewerbsvorteile
- Proprietary technology in non-invasive health monitoring.
- Expertise in digital asset development and management.
- Strategic partnerships with key players in the financial and healthcare sectors.
Ueber USBC
USBC, Inc., formerly known as Know Labs, Inc., was incorporated in 1998 and is based in Reno, Nevada. The company underwent a name change in August 2025, reflecting its strategic shift and expanded focus within the digital financial technologies sector. USBC, Inc. operates in the United States, developing transformative financial services, including digital assets and banking solutions. These solutions aim to leverage technology to enhance financial accessibility and efficiency for consumers and businesses. In addition to its fintech initiatives, USBC, Inc. is involved in non-invasive health monitoring research. This segment focuses on developing technologies that can monitor health metrics without requiring invasive procedures. The company also specializes in identifying and measuring materials or analytes using electromagnetic energy. This technology is designed to detect, record, identify, and measure the signature of various materials, with potential applications across multiple industries, including healthcare, environmental monitoring, and materials science. USBC, Inc. aims to integrate these diverse technological capabilities to create synergistic solutions that address unmet needs in both the financial and healthcare sectors. The company's strategy involves continuous innovation and strategic partnerships to expand its market reach and technological capabilities.
Was das Unternehmen tut
- Develops digital assets and banking solutions.
- Conducts research in non-invasive health monitoring.
- Identifies and measures materials using electromagnetic energy.
- Offers transformative financial services.
- Creates technologies for detecting and recording material signatures.
- Provides solutions for analyzing materials and analytes.
Geschaeftsmodell
- Develops and licenses digital financial technologies.
- Generates revenue through the sale of health monitoring devices.
- Offers subscription-based access to its material analysis technologies.
Branchenkontext
USBC, Inc. operates within the technology sector, specifically in the scientific and technical instruments industry. This industry is characterized by rapid technological advancements and increasing demand for innovative solutions in healthcare and finance. The fintech market is experiencing substantial growth, driven by the adoption of digital payment systems and the increasing demand for decentralized financial services. Similarly, the health tech market is expanding due to the growing need for remote monitoring and non-invasive diagnostic tools. USBC, Inc. aims to capitalize on these trends by developing integrated solutions that address unmet needs in both sectors. The company faces competition from established players and emerging startups, requiring a focus on differentiation and strategic partnerships to gain market share.
Wichtige Kunden
- Financial institutions seeking digital transformation solutions.
- Healthcare providers looking for non-invasive monitoring tools.
- Research institutions requiring material analysis technologies.
Finanzdaten
Chart & Info
USBC, Inc. (USBC) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga · 20. März 2026
-
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga · 10. März 2026
-
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga · 18. Feb. 2026
-
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga · 6. Feb. 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer USBC.
Kursziele
Wall-Street-Kurszielanalyse fuer USBC.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von USBC auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Klassifizierung
Branche Scientific & Technical InstrumentsAktuelle Nachrichten
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
USBC, Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for USBC?
USBC, Inc. (USBC) currently holds an AI score of 43/100, indicating low score. Key strength: Innovative technology in digital finance and health monitoring. Primary risk to monitor: Potential: Regulatory changes impacting the fintech industry.. This is not financial advice.
How frequently does USBC data refresh on this page?
USBC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven USBC's recent stock price performance?
Recent price movement in USBC, Inc. (USBC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative technology in digital finance and health monitoring. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider USBC overvalued or undervalued right now?
Determining whether USBC, Inc. (USBC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying USBC?
Before investing in USBC, Inc. (USBC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding USBC to a portfolio?
Potential reasons to consider USBC, Inc. (USBC) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Innovative technology in digital finance and health monitoring. Additionally: Expertise in electromagnetic energy-based material analysis. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of USBC?
Yes, most major brokerages offer fractional shares of USBC, Inc. (USBC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track USBC's earnings and financial reports?
USBC, Inc. (USBC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for USBC earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is limited, impacting the depth of analysis.
- AI analysis is pending, which could provide further insights.